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MRSA	transmission	dynamics	among	interconnected	acute,	and	intermediate	and	long-16 
term	care	facilities	(ILTCs)	varied	between	clones.	Clonal	complexes	ST22	and	ST45	17 
successfully	spread	throughout	the	healthcare	system,	and	are	established	in	ILTCs.	18 
MRSA	prevention	is	critical	in	ILTCs.		19 
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Abstract	(250	words)	1 
Background	2 
Methicillin-resistant	Staphylococcus	aureus	(MRSA)	is	the	most	common	healthcare-3 
associated	multidrug-resistant	organism.		Despite	the	interconnectedness	between	4 
acute	hospitals	(AHs)	and	intermediate-	and	long-term	care	facilities	(ILTCs),	the	5 
transmission	dynamics	of	MRSA	between	healthcare	settings	is	not	well	understood.		6 
	7 
Methods	8 
We	conducted	a	cross-sectional	study	in	a	network	comprising	an	AH	and	five	closely-9 
affiliated	ILTCs	in	Singapore.	A	total	of	1,700	inpatients	were	screened	for	MRSA	over	a	10 
6-week	period	in	2014.	MRSA	isolates	underwent	whole	genome	sequencing,	with	a	11 
pairwise	SNP	(Hamming	distance)	cutoff	of	60	core	genome	SNPs	used	to	define	recent	12 
transmission	clusters	(clades)	for	the	three	major	clones.	13 
	14 
Results		15 
MRSA	prevalence	in	intermediate-care	(ITCs)	(29.9%)	and	long-term	care	facilities	(LTCs)	16 
(20.4%)	were	 significantly	 higher	 than	 in	 the	 AH	 (11.8%)	 (p<0.001).	 The	 predominant	17 
clones	were	 ST22	 (183,	 47.8%),	 ST45	 (129,	 33.7%)	 and	 ST239	 (26,	 6.8%),	with	 greater	18 
diversity	 of	 STs	 in	 ILTCs	 relative	 to	 the	 AH.	 A	 large	 proportion	 of	 the	 clades	 in	 ST22	19 
(14/21,	67%)	and	ST45	(7/13,	54%)	included	inpatients	from	the	AH	and	ILTCs.	The	most	20 
frequent	source	location	of	the	inter-facility	transmissions	was	the	AH	(n=28,	36.4%).	21 
Conclusions	22 
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MRSA	transmission	dynamics	between	the	AH	and	ILTCs	were	complex.	The	greater	1 
diversity	of	STs	in	ILTCs	suggests	that	the	eco-system	in	such	settings	might	be	more	2 
conducive	for	intra-facility	transmission.	ST22	and	ST45	have	successfully	established	3 
themselves	in	ILTCs.	The	importance	of	interconnected	infection	prevention	and	control	4 
measures	and	strategies	cannot	be	overemphasized.		5 
	6 
	 	7 
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INTRODUCTION	1 
Methicillin-resistant	Staphylococcus	aureus	(MRSA)	is	one	of	the	most	common	2 
healthcare-associated	drug-resistant	organisms	globally,	especially	in	Asia	[1].	MRSA	has	3 
also	evolved	from	being	an	almost	purely	healthcare-associated	pathogen	to	one	that	is	4 
increasingly	isolated	from	the	community	and	from	livestock,	such	that	the	traditional	5 
classifications	of	healthcare-associated	MRSA	(HA-MRSA)	and	community-associated	6 
MRSA	(CA-MRSA)	are	progressively	blurred	[2].	There	remain	relatively	few	successful	7 
HA-MRSA	clones	that	have	spread	globally.	In	Asia,	the	major	successful	HA-MRSA	8 
clones	belong	to	multilocus	sequence	type	(ST)	239,	ST5	(New	York-Japan	clone),	ST22	9 
(UK-EMRSA-15)	[1,3],	and	lately	ST45	[4-6].	10 
HA-MRSA	emerged	in	Singapore	in	the	late	1970s	[7].	Between	the	late	1980s	11 
and	2000,	virtually	all	HA-MRSA	were	ST239	[3,7].	This	changed	with	the	importation	of	12 
ST22	MRSA	around	2000,	which	became	the	dominant	HA-MRSA	clone	by	2010	[3,7-9].	13 
Phylogenetic	analysis	of	representative	isolates	of	both	HA-MRSA	clones	across	three	14 
major	acute	care	hospitals	(AHs)	in	Singapore	revealed	interdependent	evolution	for	15 
both	clones,	suggesting	that	frequent	exchanges	of	patients	and	staff	had	occurred	16 
between	the	hospitals[3].	Since	2010,	a	third	global	clone	of	HA-MRSA,ST45,	has	17 
appeared	in	Singaporean	hospitals	and	is	increasing	in	prevalence	[5].	18 
Besides	horizontal	transfers	between	AHs,	vertical	transfers	of	patients	from	AHs	19 
to	intermediate-	and	long-term	care	facilities	(ILTCs)	are	common	in	Singapore.	Several	20 
studies	suggesting	that	ILTCs	–	with	their	reduced	staff-to-patient	ratios	and	less	21 
stringent	infection	prevention	practices	–	may	serve	as	reservoirs	of	MRSA	within	the	22 
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healthcare	system	[10-12].		1 
Whole	genome	sequencing	(WGS)	is	fast	emerging	as	the	new	gold	standard	for	2 
bacterial	molecular	epidemiology	[13-18].	Various	studies	looking	at	within-host	single	3 
nucleotide	polymorphism	(SNP)	diversity	and	MRSA	transmission	have	defined	the	cut-4 
off	for	a	recent	(i.e.	days	and	weeks	rather	than	months)	transmission	event	as	40	to	60	5 
pairwise	core	genome	SNPs	(Hamming	distance)	[16-18].	In	examining	the	spread	of	6 
ST239	within	and	between	intensive	care	units	of	a	hospital	in	northeastern	Thailand,	a	7 
(Hamming)	pairwise	distance	cutoff	of	60	SNPs	was	used	to	define	recent	transmission	8 
clusters	(clades)	which	were	epidemiologically	supported.	We	therefore	sought	to	9 
investigate	the	MRSA	transmission	dynamics	between	an	AH	and	its	closely	affiliated	10 
ILTCs	using	WGS,	defining	clades	for	further	analysis	via	Hamming	distance	calculations.	11 
METHODS	12 
Study	design	and	settings	13 
A	cross-sectional	study	was	conducted	in	a	1,700-bed	adult	tertiary-care	AH	in	14 
Singapore	and	its	five	most	closely-affiliated	ILTCs:	a	105-bed	rehabilitation	center	(ITC	15 
1),	a	78-bed	community	hospital	(ITC	2),	a	235-bed	community	hospital	(ITC	3),	a	234-16 
bed	nursing	home	(LTC	1),	and	a	164-bed	chronic	sick	unit	(LTC	2).	The	study	took	place	17 
over	a	six-week	period	from	June	2	to	July	9	2014.	We	randomly	selected	999	inpatients	18 
with	>48	hours	stay	in	the	AH	to	participate	in	the	study.	All	residents	of	the	ILTCs	were	19 
included.		20 
Bacterial	isolates	21 
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Nasal,	axillary,	and	groin	swabs	were	obtained	from	all	study	subjects	1 
sequentially	over	the	six-week	period	in	order	to	capture	the	contemporaneity	of	MRSA	2 
isolates	from	the	various	healthcare	facilities,	as	the	estimated	mutation	rate	of	one	3 
core	single-nucleotide	polymorphism	(SNP)	for	MRSA	is	approximately	every	six	weeks	4 
[3,15].		MRSA	was	cultured	from	the	swabs,	and	DNA	extracted	from	the	isolates,	using	5 
conventional	methods	(see	Supplementary	Methods	for	more	details).		6 
Whole	genome	sequencing	and	data	access	7 
WGS	was	performed	following	previously	described	protocols	(Supplementary	8 
Methods)	[3,15].	Short	reads	for	all	sequenced	isolates	have	been	submitted	to	the	9 
European	Nucleotide	Archive	(ENA;	http://www.ebi.ac.uk/ena/)	under	study	accession	10 
number	PRJEB9390.	Individual	accession	numbers	of	sequences	and	assemblies	for	all	11 
isolates	are	listed	in	Supplementary	Table	1.	12 
Data	analysis	13 
Quantitative	analysis		14 
The	differences	in	MRSA	prevalence	between	healthcare	facilities	were	15 
compared	using	the	Chi-square	test,	with	the	odds	ratios	and	95%	confidence	intervals	16 
(CI)	of	the	associations	estimated.	Differences	in	age	and	duration	of	stay	were	17 
compared	using	the	Student’s	t-test	and	Wilcoxon	rank-sum	test	respectively.	All	18 
statistical	analyses	were	performed	using	Stata	version	13	(Stata	Corp.,	College	Station,	19 
TX).	20 
Bioinformatics	and	phylogenetic	analysis		21 
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The	sequence	reads	were	aligned	against	the	appropriate	reference	sequences	1 
using	SMALT	(http://www.sanger.ac.uk/science/tools/smalt-0)	and	SNPs	were	identified	2 
as	described	previously	(Supplementary	Methods)	[3].	Phylogenetic	trees	for	major	3 
clones	were	constructed	using	RAxML	v7.0.4	[19].	4 
Determination	of	clades	and	parsimonious	reconstruction	of	transmissions	events	5 
Single	isolates	were	picked	as	representative	of	a	sample	site,	and	in	some	6 
individuals	there	were	multiple	isolates	from	different	sites.		Where	isolates	were	from	7 
the	same	ST,	a	primary	isolate,	representative	of	that	individual,	was	chosen;	sites	were	8 
preferentially	picked	in	the	following	sequence:	nasal,	groin,	followed	by	axilla.	Isolates	9 
belonging	to	different	STs	from	the	same	individual	were	included	in	the	analysis.		10 
Hamming	distances	were	calculated	(Supplementary	Figure	1).	This	cut-off	was	11 
then	used	to	define	clades	for	each	major	ST.	For	each	of	the	clades,	parsimonious	12 
reconstruction	of	transmissions	events	between	the	different	healthcare	locations	was	13 
conducted	using	the	phylogenetic	trees	and	associated	healthcare	setting	metadata.	The	14 
basal	isolate	in	each	clade	was	assigned	as	the	origin	state,	and	transmissions	15 
parsimoniously	reconstructed	onto	the	phylogeny	from	root	to	tips	to	identify	inter-	and	16 
intra-facility	transmission	events.	17 
Ethics	18 
Ethical	approval	for	the	study	was	obtained	from	the	Domain	Specific	Research	19 
Board,	National	Healthcare	Group.		20 
	21 
	22 
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RESULTS	1 
There	were	1,700	subjects	screened	for	MRSA	during	the	study	period,	with	a	2 
participation	rate	of	86%	at	the	ILTCs.	Subjects	across	the	healthcare	facilities	were	3 
similar	in	terms	of	age	and	gender,	whereas	subjects	in	LTCs	had	longer	duration	of	stay	4 
compared	to	subjects	in	ITCs	and	the	AH	(Table	1).	The	prevalence	of	MRSA	in	ITCs	5 
(29.9%)	and	LTCs	(20.4%)	were	significantly	higher	than	in	the	AH	(11.8%)	(p<0.001).	6 
We	sequenced	383	MRSA	isolates	from	289	subjects	from	the	prospective	7 
screening.	The	predominant	lineages	were	ST22	(n=183,	47.8%),	ST45	(n=129,	33.7%),	8 
ST239	(n=26,	6.8%),	and	ST1	(n=18,	4.7%),	with	small	numbers	of	STs	from	other	clonal	9 
complexes	(CCs)	(n=27,	7.0%).	ST22	was	more	prevalent	in	the	AH	(53%)	and	ITCs	(53%)	10 
than	in	the	LTCs	(31%)	(P=	0.005)	(Figures	1A-C).	In	contrast,	LTCs	had	the	greatest	11 
diversity	of	MRSA	clones	(Figure	1C).	CA-MRSA	clones	(ST59	and	ST30)	were	observed	in	12 
an	intermediate-care	(ST59,	n=2,	0.5%)	and	a	long-term	care	facility	(ST30,	n=2,	0.5%)	13 
respectively.	Seventy-eight	subjects	(27.0%)	had	MRSA	recovered	simultaneously	from	14 
different	body	sites,	of	which	65	(83.3%)	had	isolates	with	the	same	ST,	whereas	the	15 
remainder	had	isolates	belonging	to	two	different	STs	at	different	sites.	16 
	 Three	major	HA-MRSA	lineages	were	the	focus	of	MRSA	transmission	dynamic	17 
investigations:	ST22,	ST45	and	ST239.	In	total	270	isolates	were	subject	to	phylogenetic	18 
analysis	to	elucidate	the	fine-scale	genetic	relationships	between	representative	isolates	19 
from	the	subjects	in	each	ST	(Figure	2).		The	ST22	isolates	(n=143)	were	differentiated	by	20 
2775	SNP	sites,	the	ST45	(n=107)	by	1533	SNP	sites,	and	ST239	(n=20)	by	637	SNP	sites.		21 
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The	healthcare	origins	of	the	isolates	in	relation	to	phylogenetic	relationships	1 
were	categorized	as	heterogeneous,	with	isolates	from	all	six	settings	distributed	2 
throughout	the	phylogenies	(Figure	2).	This	is	consistent	with	the	interconnectivity	of	3 
the	healthcare	network.	The	narrow	temporal	sampling	of	this	study	enabled	us	to	look	4 
for	evidence	of	both	intra-	and	inter-facility	transmission	of	MRSA.	Isolates	that	are	part	5 
of	a	transmission	chain	will	share	a	recent	common	ancestor,	and	therefore	will	be	6 
phylogenetically	linked	and	genetically	similar.	In	the	phylogenies	of	the	three	main	7 
MRSA	populations,	there	were	clusters	of	isolates	from	the	same	healthcare	setting	8 
suggestive	of	intra-facility	transmission.	In	addition,	there	were	clusters	composed	of	9 
isolates	of	mixed	origins	indicating	that	inter-facility	transmission	has	occurred.	10 
The	majority	of	the	subjects	had	isolates	that	were	found	in	Hamming	defined	11 
clades	(Figure	2).	In	the	ST22	population,	21	clades	were	identified	comprising	124	12 
isolates	(86.7%)	(Figure	2A),	consistent	with	the	distinct	clusters	observed	on	the	tree.	13 
Similarly	in	the	ST45	population,	13	clades	comprising	95	isolates	(88.8%)	(Figure	2B)	14 
were	identified.	In	the	ST239	population	this	identified	six	clades	comprising	19/20	15 
isolates	(95.0%)	(Figure	2C).	16 
Among	the	clades,	30	(77%)	had	at	least	one	patient	from	the	AH.	The	remaining	17 
clades	comprised	of	either	ITCs	alone	(n=4),	ITCs	and	LTCs	(n=2),	or	LTCs	alone	(n=3).	18 
Except	for	two	clades	(clade	45_6	and	clade	22_12,	Supplementary	Table	1),	at	least	one	19 
subject	in	each	clade	had	been	hospitalized	in	the	study	AH	or	another	AH	within	the	20 
preceding	12	months.	The	other	subjects	in	almost	all	clades	(except	clusters	22_15	and	21 
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45_3,	Supplementary	Table	1)	who	had	not	had	an	acute	hospitalization	episode	had	1 
shared	the	same	ward	with	at	least	one	subject	with	a	recent	AH	hospitalization.			2 
The	largest	clade	was	identified	in	the	ST45	population	(Cluster	45_12,	40	3 
subjects;	Supplementary	Table	1),	comprising	predominantly	of	patients	from	the	AH,	4 
whereas	the	second	largest	clade	was	from	the	ST22	(clade	22_2,	37	subjects;	5 
Supplementary	Table	1)	which	had	the	majority	of	patients	from	ITCs.		6 
A	larger	proportion	of	the	clades	in	ST22	(14/21,	67%)	compared	to	ST45	(7/13,	7 
54%)	included	patients	and	residents	from	both	the	AH	and	ILTCs.	The	remaining	clades	8 
comprised	either	of	patients	from	the	AH	or	residents	from	ILTCs.	In	contrast,	40%	(2/5)	9 
of	the	clusters	in	the	ST239	phylogeny	comprised	of	patients	from	the	AH	only.	10 
Transmission	events	within	the	clades	were	reconstructed	parsimoniously	using	11 
phylogenetic	analyses.	In	total	193	transition	events	could	be	designated	12 
(Supplementary	Table	2).	Over	half	of	the	events	(n=116,	60.1%)	were	identified	as	13 
being	intra-facility	transmissions,	with	the	AH	having	the	largest	number	(n=59)	of	14 
events,	followed	by	ITC1	(n=18),	ITC3	(n=17),	LTC1	(n=11),	ITC2	(n=6)	and	then	LTC2	15 
(n=5).	Examining	the	inter-facility	transmissions,	the	most	frequent	source	location	of	16 
the	transmissions	was	the	AH	(n=28,	36.4%),	followed	by	ITC3	(n=21,	27.3%),	LTC2	17 
(n=12,	15.6%),	ITC2,	(n=9,	1.7%),	LTC1	(n=4,	5.2%)	and	then	ITC1	(n=3,	3.9%).	A	summary	18 
of	the	transmissions	identified	in	the	clades	is	presented	in	Figure	3	and	illustrates	the	19 
pathways	of	transmissions.		20 
	21 
DISCUSSION	22 
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This	study	provided	insights	into	the	population	dynamics	of	MRSA	within	an	1 
interconnected	healthcare	network	of	an	AH	with	its	closely	affiliated	ILTCs. MRSA	2 
prevalence	in	AH	(11.8%)	was	significantly	lowest	compared	to	intermediate-care	(ITCs)	3 
(29.9%)	and	long-term	care	facilities	(LTCs)	(20.4%)	(p<0.001).	The	predominant	clones	4 
were	ST22	(183,	47.8%),	ST45	(129,	33.7%)	and	ST239	(26,	6.8%),	with	greater	diversity	5 
of	STs	in	ILTCs	relative	to	the	AH.	A	large	proportion	of	the	clades	in	ST22	(14/21,	67%)	6 
and	ST45	(7/13,	54%)	consists	of	inpatients	from	both	the	AH	and	ILTCs.	AH	was	the	7 
major	source	location	of	inter-facility	transmissions	(n=28,	36.4%).		8 
The	transmission	of	MRSA	within	the	network	is	a	complex	one.	9 
Contemporaneously,	different	MRSA	clones	were	identified	within	the	same	healthcare	10 
institution	and	the	same	MRSA	clade	observed	across	healthcare	settings.		The	higher	11 
MRSA	prevalence	observed	in	ILTCs	relative	to	the	AH	in	our	study	was	consistent	with	12 
other	studies	[10-12],	and	–	combined	with	the	finding	of	a	greater	diversity	of	STs	in	13 
ILTCs	–	indirectly	suggests	that	infection	prevention	practices	are	less	stringent	in	the	14 
ILTCs.			The	observation	that	the	predominant	clonal	lineages	were	ST22,	ST45	and	15 
ST239	also	reflects	what	was	previously	reported	[5],	with	the	major	change	being	that	16 
of	the	increased	prevalence	of	ST45	vis-à-vis	ST239.		17 
The	Hamming	distance	defined	clusters	allowed	us	to	examine	the	recent	18 
dynamics	of	the	MRSA.	Our	results	suggest	that	the	current	dominant	lineage	ST22	19 
appeared	to	have	successfully	transmitted	from	acute	hospitals	to	ILTCs.	In	the	ST22	20 
phylogenetic	tree,	isolates	from	ILTCs	interspersed	with	isolates	from	the	AH	within	21 
many	clades.	Furthermore,	almost	1	in	5	clades	in	ST22	included	only	patients/residents	22 
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from	ILTCs,	suggesting	that	ST22	was	being	spread	independently	within	ILTCs.	The	1 
same	findings	were	made	for	ST45,	with	a	suggestion	that	isolates	from	this	ST	might	2 
preferentially	spread	within	ILTCs	given	that	40%	of	the	clades	comprised	of	isolates	3 
obtained	only	from	ILTC	subjects.	Despite	ST239	being	the	oldest	HA-MRSA	clone	in	4 
Singapore,	it	did	not	appear	to	have	transmitted	as	successfully	as	ST22	and	ST45	across	5 
healthcare	settings.	It	is	unclear	if	this	was	the	result	of	ST239	being	outcompeted	at	the	6 
ILTCs	by	the	other	two	STs,	or	if	differential	infection	control	practices	at	the	various	7 
healthcare	facilities	had	played	a	role	in	the	divergent	distribution	of	the	STs.	8 
Parsimonious	reconstruction	of	transmission	events	suggests	that	the	AH	was	9 
the	source	of	MRSA	with	regards	to	transmission	between	the	AH	and	the	ITCs;	10 
however,	it	was	the	reservoir	with	regards	to	the	transmission	from	LTCs.	This`	result	11 
seems	incongruent	with	the	higher	prevalence	of	MRSA	in	ILTCs	but	may	be	explained	12 
by	the	general	flow	of	patient	movements.	AH	inpatients	tend	to	be	transferred	to	ITCs	13 
and	are	then	discharged	home,	with	only	a	small	percentage	requiring	transfer	back	to	14 
the	AH.	LTCs	on	the	other	hand	are	the	terminal	care	facility	for	patients	transferred	15 
there,	who	stay	until	they	are	deceased	or	develop	an	acute	event	requiring	transfer	16 
back	to	the	AH.	Moreover,	far	fewer	patients	are	transferred	directly	from	AH	to	LTC	as	17 
compared	to	AH	to	ITC,	or	ITC	to	LTC.	18 
	 Our	study	was	limited	by	the	cross-sectional	design	and	short	sampling	frame,	19 
and	the	results	based	on	genomic	analysis	will	need	validation	via	a	longitudinal	study.	20 
Second,	the	overall	movement	of	patients	and	staff	between	the	healthcare	facilities	21 
was	not	evaluated,	factors	which	may	inform	resolution	to	the	net	transmission	of	22 
Page	14	of	21	
MRSA	between	the	various	healthcare	facilities.	A	higher	participation	rate	at	both	the	1 
AH	and	ILTCs	would	have	made	for	a	more	rigorous	study;	however,	the	results	are	2 
unlikely	to	change	significantly	given	the	participation	rate	of	86%.	3 
	 In	conclusion,	we	found	that	the	transmission	dynamics	of	MRSA	between	an	AH	4 
and	its	closely	affiliated	ILTCs	varied	between	MRSA	CCs.	ST22	and	ST45	have	not	only	5 
receded	ST239	in	acute	hospitals	[3,5],	but	have	also	successfully	established	6 
themselves	in	the	ILTCs.	The	greater	diversity	of	STs	in	ILTCs	suggests	that	the	eco-7 
system	in	such	settings	might	be	more	conducive	for	intra-facility	transmission.	8 
Interconnected	infection	prevention	and	control	measures	and	strategies,	including	9 
sharing	of	information	on	MRSA-colonizers	and	best	practices,	should	be	instituted	10 
across	acute	hospitals	and	ILTCs	in	healthcare	networks.	11 
	12 
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Figures	1 
Figure	1.		2 
Distribution	of	methicillin-resistant	Staphylococcus	aureus	(MRSA)	clones	in	the	A)	acute	3 
hospital	(AH),	B)	intermediate-care	(ITC),	and	C)	long-term	care	(LTC)	facilities,	by	total	4 
number	of	isolates	(n=383)	5 
	6 
Figure	2.	7 
Population	structures	of	the	dominant	methicillin-resistant	Staphylococcus	aureus	8 
(MRSA)	clones	circulating	in	health	care	facilities	defined	as	maximum	likelihood	9 
phylogenetic	trees	based	on	core	genome	SNPs	of:	A)	ST22	B)	ST45;	and	C)	ST239.	Also	10 
shown	(right-hand	panels)	are:	clades	of	isolates	defined	by	the	pairwise	60	SNP	cutoff	11 
(clusters	are	alternatingly	colored	from	top	to	bottom,	blue	and	red)	and	healthcare	12 
facilities.	The	trees	are	rooted	with	the	reference	used	for	mapping	for	each	ST.	In	the	13 
case	of	CA-347,	the	ST45	reference,	the	branch	has	been	collapsed.	Tree	branches	14 
colored	blue	link	isolates	that	belong	to	a	clade	(as	indicated	in	the	right-hand	panel).	15 
One	ST22	isolate,	CD141496,	single	locus	variant	of	ST22,	was	excluded	from	the	16 
phylogenetic	analysis	due	to	its	genetic	distance	from	the	rest	of	the	isolates	in	the	17 
collection.	18 
	19 
Figure	3	20 
Schematic	representation	of	the	transmission	dynamics	of	methicillin-resistant	21 
Staphylococcus	aureus	(MRSA)	in	the	healthcare	settings.		For	each	of	the	clusters,	22 
Page	17	of	21	
parsimonious	reconstruction	of	transmissions	events	between	the	different	healthcare	1 
facilities	were	conducted	using	the	phylogenetic	trees	and	healthcare	setting	metadata.	2 
The	origin	of	the	basal	isolate	in	each	cluster	was	assigned	as	the	initial	state,	and	3 
subsequent	transmissions	parsimoniously	reconstructed	to	identify	inter-	and	intra-4 
facility	transmission	events.	The	arrows	are	scaled	in	size	according	to	the	number	of	5 
observed	inter-facility	transmission	events,	and	the	circles	representing	the	6	different	6 
healthcare	locations	are	scaled	in	size	according	to	the	number	of	intra-facility	7 
transmission	events	identified.	8 
	 	9 
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FIGURES	
Figure	1-A.		
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Figure	1-B.	Distribution	of	Clonal	Complexes	in	Intermediate	Care	Facilities	(n=118)	
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Figure	1-C.		
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